- Home
- CLPT vs ABEO Comparison
CLPT vs ABEO Comparison
Compare CLPT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- ABEO
- Stock Information
- Founded
- CLPT 1998
- ABEO 1974
- Country
- CLPT United States
- ABEO United States
- Employees
- CLPT N/A
- ABEO N/A
- Industry
- CLPT Medical/Dental Instruments
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- ABEO Health Care
- Exchange
- CLPT Nasdaq
- ABEO Nasdaq
- Market Cap
- CLPT 317.4M
- ABEO 332.0M
- IPO Year
- CLPT N/A
- ABEO 1980
- Fundamental
- Price
- CLPT $10.49
- ABEO $6.83
- Analyst Decision
- CLPT Strong Buy
- ABEO Strong Buy
- Analyst Count
- CLPT 3
- ABEO 6
- Target Price
- CLPT $27.67
- ABEO $18.17
- AVG Volume (30 Days)
- CLPT 375.5K
- ABEO 702.3K
- Earning Date
- CLPT 08-12-2025
- ABEO 08-14-2025
- Dividend Yield
- CLPT N/A
- ABEO N/A
- EPS Growth
- CLPT N/A
- ABEO N/A
- EPS
- CLPT N/A
- ABEO 0.99
- Revenue
- CLPT $33,593,000.00
- ABEO $400,000.00
- Revenue This Year
- CLPT $22.34
- ABEO N/A
- Revenue Next Year
- CLPT $25.50
- ABEO $339.63
- P/E Ratio
- CLPT N/A
- ABEO $6.91
- Revenue Growth
- CLPT 19.68
- ABEO N/A
- 52 Week Low
- CLPT $9.76
- ABEO $3.93
- 52 Week High
- CLPT $19.22
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- CLPT 44.46
- ABEO 52.71
- Support Level
- CLPT $10.42
- ABEO $6.70
- Resistance Level
- CLPT $10.88
- ABEO $7.15
- Average True Range (ATR)
- CLPT 0.52
- ABEO 0.31
- MACD
- CLPT -0.01
- ABEO -0.02
- Stochastic Oscillator
- CLPT 22.75
- ABEO 46.62
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.